Preprint / Version 1

Does Dihydrotestosterone Affect Physical Performance, Or Parameters Known To Affect Physical Performance Capacity Independently From The Effect Of Testosterone?

A Protocol For A Systematic Review.

##article.authors##

  • Blair Hamilton Manchester Metropolitan University
  • Daniel Martin Department of Sport and Exercise Sciences, Manchester Metropolitan University Institute of Sport, Manchester, UK
  • Alun Williams Department of Sport and Exercise Sciences, Manchester Metropolitan University Institute of Sport, Manchester, UK https://orcid.org/0000-0002-8052-8184

DOI:

https://doi.org/10.51224/SRXIV.436

Keywords:

Dihydrotestosterone, athletic performance, Human, Animal

Abstract

Background: The role of hormones in human physical performance has been a subject of extensive research. Testosterone has been widely studied for its significant impact on muscle mass and muscle protein synthesis, strength, and physical performance. However, the role of dihydrotestosterone (DHT), a more potent androgen derived from testosterone in physical performance needs to be clarified, leading to a gap in the literature and creating an opportunity for a systematic review. Aim: To systematically review the existing literature to elucidate the independent effects of DHT on physical performance in humans and animal models, separate from the effects of testosterone. Methods: Studies published up to 31/07/2024 will be retrieved from three electronic sources (PubMed, Embase, SportDiscus). Keywords relevant to all searches will include “dihydrotestosterone or DHT", “performance", “human", and “animal”. This study will adhere to PRISMA guidelines. The primary a priori outcome measures will include changes in human performance, such as any laboratory or field assessment involving exercise (e.g., power, VȮ2max, force, torque, time, etc.) Secondary a priori outcomes in animal and human models will include parameters affecting physical performance capacity (e.g., [Hb], HCt, body composition and other anthropometric measurements including muscle mass, overall, regionally, stroke volume, hormones, gene expression, etc.).

Metrics

Metrics Loading ...

References

Cardinale M, Stone MH. Is testosterone influencing explosive performance? The Journal of Strength & Conditioning Research. 2006;20(1):103-7.

Vanny P, Moon J. Physiological and Psychological Effects of Testosterone on Sport Performance: A Critical Review of Literature. Sport Journal. 2015.

Hilton EN, Lundberg TR. Transgender women in the female category of sport: perspectives on testosterone suppression and performance advantage. Sports Medicine. 2021;51:199-214.

Hamilton B, Guppy F, Pitsiladis Y. Comment on:“Transgender Women in the Female Category of Sport: Perspectives on Testosterone Suppression and Performance Advantage”. Sports Medicine. 2024;54(1):237-42.

Senefeld JW, Hunter SK. Hormonal basis of biological sex differences in human athletic performance. Endocrinology. 2024;165(5):bqae036.

Handelsman DJ, Hirschberg AL, Bermon S. Circulating testosterone as the hormonal basis of sex differences in athletic performance. Endocrine reviews. 2018;39(5):803-29.

Karkazis K, Jordan-Young RM. The Powers of Testosterone. Feminist formations. 2018;30(2):1-39.

Griggs RC, Kingston W, Jozefowicz RF, Herr BE, Forbes G, Halliday D. Effect of testosterone on muscle mass and muscle protein synthesis. Journal of Applied Physiology. 1989;66(1):498-503.

Chiu H-T, Shih M-T, Chen W-L. Examining the association between grip strength and testosterone. The Aging Male. 2020;23(5):915-22.

Srinivas-Shankar U, Roberts SA, Connolly MJ, O'Connell MD, Adams JE, Oldham JA, et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. The Journal of Clinical Endocrinology & Metabolism. 2010;95(2):639-50.

Kinter KJ, Amraei R, Anekar AA. Biochemistry, dihydrotestosterone. StatPearls [internet]: StatPearls Publishing; 2023.

Chen H, Ge R-S, Zirkin BR. Leydig cells: from stem cells to aging. Molecular and cellular endocrinology. 2009;306(1-2):9-16.

Shin YS, You JH, Cha JS, Park JK. The relationship between serum total testosterone and free testosterone levels with serum hemoglobin and hematocrit levels: a study in 1221 men. The Aging Male. 2016;19(4):209-14.

Swerdloff RS, Dudley RE, Page ST, Wang C, Salameh WA. Dihydrotestosterone: biochemistry, physiology, and clinical implications of elevated blood levels. Endocrine reviews. 2017;38(3):220-54.

Hsu B, Cumming RG, Hirani V, Blyth FM, Naganathan V, Le Couteur DG, et al. Temporal trend in androgen status and androgen-sensitive outcomes in older men. The Journal of Clinical Endocrinology & Metabolism. 2016;101(4):1836-46.

Smith AA, Toone R, Peacock O, Drawer S, Stokes KA, Cook CJ. Dihydrotestosterone is elevated following sprint exercise in healthy young men. Journal of Applied Physiology. 2013;114(10):1435-40.

Pöllänen E, Kangas R, Horttanainen M, Niskala P, Kaprio J, Butler‐Browne G, et al. Intramuscular sex steroid hormones are associated with skeletal muscle strength and power in women with different hormonal status. Aging cell. 2015;14(2):236-48.

Zeng F, Zhao H, Liao J. Androgen interacts with exercise through the mTOR pathway to induce skeletal muscle hypertrophy. Biology of sport. 2017;34(4):313-21.

Aydogdu A, Swerdloff RS. Emerging medication for the treatment of male hypogonadism. Expert Opinion on Emerging Drugs. 2016;21(3):255-66.

Rey RA, Grinspon RP. Androgen treatment in adolescent males with hypogonadism. American Journal of Men's Health. 2020;14(3):1557988320922443.

World Anti Doping Agency. World Anti‐Doping Code‐International Standard: Prohibited List 2024

Sacks H, Chalmers TC, Smith Jr H. Randomized versus historical controls for clinical trials. The American journal of medicine. 1982;72(2):233-40.

Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Jama. 1995;273(5):408-12.

Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group* t. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine. 2009;151(4):264-9.

Sarkis-Onofre R, Catalá-López F, Aromataris E, Lockwood C. How to properly use the PRISMA Statement. Systematic Reviews. 2021;10:1-3.

Cohen J. Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit. Psychological bulletin. 1968;70(4):213.

Lee E, Dobbins M, DeCorby K, McRae L, Tirilis D, Husson H. An optimal search filter for retrieving systematic reviews and meta-analyses. BMC medical research methodology. 2012;12:1-11.

Sterne JA, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. bmj. 2019;366.

Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. bmj. 2016;355.

Additional Files

Posted

2024-07-30